Overview
Sweden non-animal chemical safety tester's Q1 revenue rose 10% yr/yr to SEK 15.0 mln
Gross margin fell to 69% from 75% a year earlier
Company completed SEK 17.5 mln directed share issue to institutional investor
Outlook
Company says it is well positioned to continue delivering on its growth plan
Result Drivers
NEGATIVE FX AND SUBSIDIARY TRANSITION - Co said 10% revenue growth was achieved despite negative foreign exchange effects and a subsidiary undergoing a transition, per CEO Peter Nählstedt
GROWING INDUSTRIAL INTEREST - Co said GARD®air platform drew increased interest from industry players for non-animal respiratory sensitization testing
NEW CUSTOMER WINS - Co secured a new global cosmetics group as a customer for GARD®
Company press release: ID:nMFNb8CYBw
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
SEK 15 mln
Q1 EPS
-SEK 0.06
Analyst Coverage
Wall Street's median 12-month price target for SenzaGen AB is SEK13.00, about 129.7% above its May 11 closing price of SEK5.66
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)